Jan 15, 2021 | Press Releases
– Signs distribution agreement with Galaxy Pharma Ltd., the clear market leader of infertility products and services in Pakistan- Seeks to expand access to infertility care in the fifth most populous country in the world, Pakistan, with approximately 212 million...
Jan 15, 2021 | Press Releases
– Signs distribution agreement with Galaxy Pharma Ltd., the clear market leader of infertility products and services in Pakistan- Seeks to expand access to infertility care in the fifth most populous country in the world, Pakistan, with approximately 212 million...
Jan 7, 2021 | Press Releases
Key Developments and Future Initiatives Position INVOcell® Within the Severely Underserved Fertility MarketSARASOTA, Fla., Jan. 7, 2021 – INVO Bioscience, Inc. (NASDAQ: INVO) (“Company”) (‘INVO”), a medical device company...
Jan 7, 2021 | Press Releases
Key Developments and Future Initiatives Position INVOcell® Within the Severely Underserved Fertility MarketSARASOTA, Fla., Jan. 7, 2021 – INVO Bioscience, Inc. (NASDAQ: INVO) (“Company”) (‘INVO”), a medical device company...
Nov 25, 2020 | Press Releases
– Malaysia represents a significant addressable market opportunity with approximately 10% of the population suffering from infertility.- idsMED is one of the largest and most well-respected medical solutions providers in the region.- Product registration is...
Nov 18, 2020 | Press Releases
SARASOTA, Fla., Nov. 18, 2020 – INVO Bioscience, Inc. (Nasdaq: INVO) developers of INVOcell®, the world’s only in vivo Intravaginal Culture System, today announced the formation of its Scientific Advisory Board (SAB) with the appointment of...
